Shareholders of these three health-care stocks could be wishing for a do-over for the start of July.
One of the week's big losers appears to have been hurt by being dropped from a well-known index. Another reported late-stage clinical study results that caused some to worry. And the third was stung by the posting of a warning letter by the U.S. Food and Drug Administration.
Which three health-care stocks were crushed by the market this week? Find out by watching the slideshow below.
Keith Speights owns shares of Apple. The Motley Fool recommends Apple, Google (A shares), Google (C shares), and Netflix. The Motley Fool owns shares of Apple, Google (A shares), Google (C shares), and Netflix. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
Investors Just Doubled Their Money on This Stock
Alexion is paying $8.4 billion to buy Synageva, a company without any sales, so in today's episode we're digging into this deal to see what it may mean to biotech investors.
Why Shares of Synageva BioPharma Corp. Skyrocketed Today
Shares of the rare disease drugmaker Synageva BioPharma exploded higher this morning. Here's why.
An $8 Billion Hedge Fund Bought This Extremely Risky Stock: Should You?
The healthcare gurus known as the Baker Brothers have amassed a huge position in the orphan drugmaker Synageva BioPharma Corp. Should investors follow in their footsteps?